Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age.

The Oncotype DX 21-gene Recurrence Score algorithm is critically affected by patient age. These findings emphasise the need for the consideration of patient age, particularly for women younger than 50, in the development and application of genomic-based algorithms for breast cancer care.